Berkeley, CA, United States of America

Mark Saifer


Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 556(Granted Patents)


Company Filing History:


Years Active: 1991-1995

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark Saifer: Innovator in Biochemical Conjugates

Introduction

Mark Saifer is a notable inventor based in Berkeley, California. He has made significant contributions to the field of biochemistry, particularly in the development of innovative conjugates that enhance the properties of superoxide dismutase. With a total of four patents to his name, Saifer's work has implications for various medical and pharmaceutical applications.

Latest Patents

Saifer's latest patents include "Conjugates of superoxide dismutase coupled to high molecular weight" and "Intermediates for conjugation of polypeptides with high molecular weight." These patents describe a biologically persistent, water-soluble, substantially non-immunogenic, and substantially non-antigenic conjugate of superoxide dismutase. The conjugate is prepared by coupling one to five strands of a polyalkylene glycol, which can be polyethylene glycol or a polyethylene-polypropylene glycol copolymer. The polyalkylene glycol used has an average molecular weight ranging from about 35,000 to 1,000,000.

Career Highlights

Throughout his career, Mark Saifer has worked with several companies, including DDI Pharmaceuticals, Inc. and Oxis International, Inc. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in the field of biochemistry.

Collaborations

Some of Saifer's notable coworkers include Ralph Somack and L. David Williams. Their collaborative efforts have likely played a role in the development of his patented technologies.

Conclusion

Mark Saifer's contributions to the field of biochemistry through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of new therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…